Company / SG&A Expense
Surgery Partners, Inc. SG&A Expense History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$138.7M
FY2024
5-year range
$97.1M / $138.7M
FY2020-FY2024
Trend
+14.7%
vs FY2023
Sector context
#124 of 158
Health Care
What the data says
Surgery Partners, Inc.'s sg&a expense of $139M is lower than 78% of companies in the Health Care sector (FY2024). SG&A Expense has fluctuated over the past 10 years, ranging from $47M in FY2017 to $139M in FY2024.
Based on SEC 10-K filings.
$139M in FY2024 with a 5-year CAGR of +9.4%.
Increased from $102M to $139M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +10.1%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 158This company $138.7M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.4%, indicating consistent growth.
- In FY2024, sg&a expense increased 14.7% year-over-year.
- Ranks #124 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.31 (distress zone, below 1.8 threshold)
- Negative profit margin: -14.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $138.7M | +14.7% |
| FY2023 | $120.9M | +18.3% |
| FY2022 | $102.2M | -1.7% |
| FY2021 | $104.0M | +7.1% |
| FY2020 | $97.1M | +9.6% |
| FY2019 | $88.6M | -5.3% |
| FY2018 | $93.6M | +100.0% |
| FY2017 | $46.8M | -22.3% |
| FY2016 | $60.2M | +7.6% |
| FY2015 | $56.0M | +78.0% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026